Gene · 56848
Papers2,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. | Nat Commun | 2023 | 37907536 | PubTator, text mining | PubMed |
| Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review. | Medicine (Baltimore) | 2023 | 37904441 | PubTator, text mining | PubMed |
| Detection of Fatigue Cracks for Concrete Structures by Using Carbon Ink-Based Conductive Skin and Electrical Resistance Tomography. | Sensors (Basel) | 2023 | 37896476 | PubTator, text mining | PubMed |
| PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development. | Cancers (Basel) | 2023 | 37894409 | PubTator, text mining | PubMed |
| Characterising the Physiological Responses of Chinook Salmon (Oncorhynchus tshawytscha) Subjected to Heat and Oxygen Stress. | Biology (Basel) | 2023 | 37887052 | PubTator, text mining | PubMed |
| The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2. | Curr Issues Mol Biol | 2023 | 37886946 | PubTator, text mining | PubMed |
| Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels. | Curr Issues Mol Biol | 2023 | 37886933 | PubTator, text mining | PubMed |
| Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management. | Bioinformation | 2023 | 37886152 | PubTator, text mining | PubMed |
| Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue. | Front Immunol | 2023 | 37868972 | PubTator, text mining | PubMed |
| Sphingolipid metabolism in brain insulin resistance and neurological diseases. | Front Endocrinol (Lausanne) | 2023 | 37867511 | PubTator, text mining | PubMed |
| The role of sphingosine-1-phosphate in autophagy and related disorders. | Cell Death Discov | 2023 | 37852968 | PubTator, text mining | PubMed |
| Red Rice Seed Coat Targeting SPHK2 Ameliorated Alcoholic Liver Disease via Restored Intestinal Barrier and Improved Gut Microbiota in Mice. | Nutrients | 2023 | 37836459 | PubTator, text mining | PubMed |
| Histone and Histone Acetylation-Related Alterations of Gene Expression in Uninvolved Psoriatic Skin and Their Effects on Cell Proliferation, Differentiation, and Immune Responses. | Int J Mol Sci | 2023 | 37833997 | PubTator, text mining | PubMed |
| The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis. | Cells | 2023 | 37830566 | PubTator, text mining | PubMed |
| The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. | Front Endocrinol (Lausanne) | 2023 | 37795365 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| The emerging role of lncRNAs in osteoarthritis development and potential therapy. | Front Genet | 2023 | 37779916 | PubTator, text mining | PubMed |
| ATF3 regulates SPHK1 in cardiomyocyte injury via endoplasmic reticulum stress. | Immun Inflamm Dis | 2023 | 37773702 | PubTator, text mining | PubMed |
| Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care. | Pharmaceutics | 2023 | 37765300 | PubTator, text mining | PubMed |
| Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. | Cancers (Basel) | 2023 | 37760612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56848/papers?page=8